New hope for tough schizophrenia cases? phase 3 trial launches
NCT ID NCT07184619
First seen Nov 01, 2025 · Last updated May 10, 2026 · Updated 26 times
Summary
This study tests whether a new drug called evenamide can help people with treatment-resistant schizophrenia whose symptoms are not well controlled by their current antipsychotic medication. About 400 adults will receive either evenamide or a placebo added to their usual treatment for 12 weeks. The goal is to see if evenamide reduces symptoms like hallucinations and delusions more than placebo, and to check its safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT RESISTANT SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine
RECRUITINGBaltimore, Maryland, 21224, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Grady Behavioral Health Center, -Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine
NOT_YET_RECRUITINGAtlanta, Georgia, 30322, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Manhattan Psychiatric Center, The Nathan Kline Institute for Psychiatric Research
RECRUITINGNew York, New York, 10035, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
UCLA DGSOM, UCLA Health, UCLA Semel Institute
RECRUITINGLos Angeles, California, 90095, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Miami, Miller School of Medicine; Jackson Behavioral Health Hospital
NOT_YET_RECRUITINGMiami, Florida, 33136, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.